Operating Expenses
Business Exit Costs
Analysis
StatementIncome Statement
SectionOperating Expenses
Metric ID:
adi_business_exit_costsBusiness Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Medical-Surgical Solutions | $25M | $12M | $14M | $2M | $9.25M | $9.25M | $9.25M | $9.25M |
| North American Pharmaceutical | — | — | $1M | $0 | $750K | $750K | $750K | $750K |
| International | — | $0 | — | — | — | — | — | — |
| Oncology & Multispecialty | $0 | — | $0 | $0 | — | — | — | — |
| Prescription Technology Solutions | $0 | $0 | $0 | $3M | $0 | $0 | $0 | $0 |
| U.S. Pharmaceutical | — | $1M | — | — | — | — | — | — |
| Total | — | — | — | — | — | — | — | — |
International, Oncology & Multispecialty, Prescription Technology Solutions, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
